Reciprocal stimulation between TNF-α and nitric oxide may exacerbate CNS inflammation in experimental autoimmune encephalomyelitis

Journal of Neuroimmunology

Volumn 89, Issue 1-2, 1998, Pages 122-130

  Sun, Deming ^a,b   Coleclough, Christopher ^c   Cao, Ligong ^a,b   Hu, Xianzhen ^a,b   Sun, Sheher ^a,b   Whitaker, John N ^a,b  

^a UAB Department of Neurology   (United States)

^b Ctr Neuroimmunology Univ A   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

CNS inflammation; Glia; Glia T cell interaction; Inducible nitric oxide synthase (iNOS); Nitric oxide (NO); Pathogenesis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 1; RECOMBINANT INTERLEUKIN 4; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CELL INTERACTION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; GLIA CELL; IMMUNOPATHOGENESIS; INFLAMMATION; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ANIMALS; ARGININE; ASTROCYTES; CELL COMMUNICATION; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; INTERFERON TYPE II; INTERLEUKIN-1; INTERLEUKIN-4; MYELIN BASIC PROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PENICILLAMINE; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032516782     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00124-6     Document Type: Article

References (60)

1. Aloisi F., Sun D., Levi G., Wekerle H. Establishment of a permanent rat brain-derived glial cell line as a source of purified oligodendrocyte-type 2 astrocyte lineage cell populations. J. Neurosci. Res. 27:1990;16-24.
2. Aloisi F., Carè A., Borsellino G., Gallo P., Rosa S., Bassani A., Cabibbo A., Testa U., Levi G., Peschle C. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α J. Immunol. 149:1992;2358-2366.
3. Baker D., Butler D., Scallon B.J., O'Neill J.K., Turk J.L., Feldmann M. Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur. J. Immunol. 24:1994;2040-2048.
4. Bauer H., Jung T., Tsikas D., Stichtenoth D.O., Frölich J.C., Neumann C. Nitric oxide inhibits the secretion of T-helper 1- and T-helper 2-associated cytokines in activated human T cells. Immunology. 90:1997;205-211.
5. Benoist C., Mathis D. Cell death mediators in autoimmune diabetes - No shortage of suspects. Cell. 89:1997;1-3.
6. Bo L., Dawson T.M., Wesselingh S., Mork S., Choi S., Kong P.A., Hanley D.X., Trapp B.D. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:1994;778-786.
7. Boullerne A.I., Petry K.G., Meynard M., Geffard M. Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine. J. Neuroimmunol. 60:1995;117-124.
8. Brenner T., Brocke S., Szafer F., Sobel R.A., Parkinson J.F.X., Perez D.H., Steinman L. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:1997;2940-2946.
9. Corbett J.A., Mikhael A., Shimizu J., Frederick K., Misko T.P., McDaniel M.L.X., Kanagawa O., Unanue E.R. Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc. Natl. Acad. Sci. USA. 90:1993;8992-8995.
10. Degroot C.J.A., Ruuls S.R., Theeuwes J.W.M., Dijkstra C.D., Vandervalk P. Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:1997;10-20.
11. Ding M.Z., St. Pierre B.A., Parkinson J.F., Medberry P., Wong J.L., Rogers N.E., Ignarro L.J., Merrill J.E. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia - A kinetic analysis. J. Biol. Chem. 272:1997;11327-11335.
12. Dopp J.M., Mackenzie-Graham A., Otero G.C., Merrill J.E. Differential expression, cytokine modulation, and specific functions of type-1 and type-2 tumor necrosis factor receptors in rat glia. J. Neuroimmunol. 75:1997;104-112.
13. Feinberg A.P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:1983;6-13.
14. Fuseler J.W., Conner E.M., Davis J.M., Wolf R.E., Grisham M.B. Cytokine and nitric oxide production in the acute phase of bacterial cell wall-induced arthritis. Inflammation. 21:1997;113-131.
15. Galea E., Reis D.J., Feinstein D.L. Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37:1994;406-414.
16. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal. Biochem. 126:1982;131-138.
17. Hooper D.C., Bagasra O., Marini J.C., Zborek A., Ohnishi S.T., Kean R., Champion J.M., Sarker A.B., Bobroski L., Farber J.L.et al. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 94:1997;2528-2533.
18. Huang F.P., Feng G.J., Lindop G., Stott D.I., Liew F.Y. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL:MP-lpr:lpr mice. J. Exp. Med. 183:1996;1447-1459.
19. Liew F.Y. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol. 7:1995;396-399.
20. Liew F.Y., Li Y., Severn A., Millott S., Schmidt J., Salter M., Moncada S. A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages. Eur. J. Immunol. 21:1991;2489-2494.
21. Lin R.F., Lin T.-S., Tilton R.G., Cross A.H. Nitric oxide localized to spinal cords of mice with experimental allergic encephalomyelitis: an electron paramagnetic resonance study. J. Exp. Med. 178:1993;643-648.
22. Linke A.T., Male D.K. Strain-specific variation in constitutive and inducible expression of MHC class II, class I and ICAM-1 on rat cerebral endothelium. Immunology. 82:1994;88-94.
23. Liu J., Marino M.W., Wong G., Grail D., Dunn A., Bettadapura J., Slavin A., Old L., Bernard C.C.A. TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination. Nature Med. 4:1998;78-81.
24. Mackenzie-Graham A.J., Mitrovic B., Smoll A., Merrill J.E. Differential sensitivity to nitric oxide in immortalized, cloned murine oligodendrocyte cell lines. Dev. Neurosci. 16:1994;162-171.
25. Malfroy B., Doctrow S.R., Orr P.L., Tocco G., Fedoseyeva E.V., Benichou G. Prevention and suppression of autoimmune encephalomyelitis by EUK-8, a synthetic catalytic scavenger of oxygen-reactive metabolites. Cell. Immunol. 177:1997;62-68.
26. McCartney-Francis N., Allen J.B., Mizel D.E., Albina J.E., Xie Q.W., Nathan C.F.X., Wahl S.M. Suppression of arthritis by an inhibitor of nitric oxide synthase. J. Exp. Med. 178:1993;749-754.
27. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
28. Mitrovic B., Ignarro L.J., Vinters H.V., Akers M.A., Schmid I., Uittenbogaart C., Merrill J.E. Nitric oxide induces necrotic but not apoptotic cell death in oligodendrocytes. Neuroscience. 65:1995;531-539.
29. Mizuno T., Sawada M., Marunouchi T., Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem. Biophys. Res. Commun. 205:1994;1907-1915.
30. Moore S.C., McCormack J.M., Armendariz E., Gatewood J., Walker W.S. Phenotypes and alloantigen-presenting activity of individual clones of microglia derived from the mouse brain. J. Neuroimmunol. 41:1992;203-214.
31. Nathan C. Natural resistance and nitric oxide. Cell. 82:1995;873-876.
32. Nathan C., Xie Q.W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:1994;13725-13728.
33. Okuda Y., Nakatsuji Y., Fujimura H., Esumi H., Ogura T., Yanagihara T., Sakoda S. Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis. J. Neuroimmunol. 62:1995;103-112.
34. Okuda Y., Sakoda S., Fujimura H., Yanagihara T. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:1997;107-116.
35. Powell M.B., Mitchell D., Lederman J., Buckmeier J., Zamvil S.S., Graham M., Ruddle N.H., Steinman L. Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. Int. Immunol. 2:1990;539-544.
36. Risau W., Engelhardt B., Wekerle H. Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro. J. Cell. Biol. 110:1990;1757-1766.
37. Ruddle N.H., Bergman C.M., McGrath K.M., Lingenheld E.G., Grunnet M.L., Padula S.J., Clark R.B. An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J. Exp. Med. 172:1990;1193-1200.
38. Ruuls S.R., Van Der Linden S., Sontrop K., Huitinga I., Dijkstra C.D. Aggravation of experimental allergic encephalomyelitis (EAE) by administration of nitric oxide (NO) synthase inhibitors. Clin. Exp. Immunol. 103:1996;467-474.
39. Schmidt H.H., Walter U. NO at work. Cell. 78:1994;919-925.
40. Selmaj K.W., Raine C. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:1988;339-346.
41. Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc. Natl. Acad. Sci. USA. 93:1996;2253-2256.
42. Suarez-Pinzon W.L., Szabó C., Rabinovitch A. Development of autoimmune diabetes in NOD mice is associated with the formation of peroxynitrite in pancreatic islet β-cells. Diabetes. 46:1997;907-911.
43. Sun D. Enhanced interferon-gamma-induced Ia-antigen expression by glial cells after previous exposure to this cytokine. J. Neuroimmunol. 34:1991;205-214.
44. Sun D., Wekerle H. Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes. Nature. 320:1986;70-72.
45. Sun D., Hu X., Le J., Swanborg R.H. Characterization of brain-isolated rat encephalitogenic T cell lines. Eur. J. Immunol. 24:1994;1359-1364.
46. Sun D., Hu X., Shah R., Coleclough C. The pattern of cytokine gene expression induced in rat T cells specific for myelin basic protein depends on the type and quality of antigenic stimulus. Cell. Immunol. 166:1995;1-8.
47. Sun D., Hu X., Shah R., Zhang L., Coleclough C. Production of tumore necrosis factor-α as a result of glia-T cell interaction correlates with the pathogenic activity of myelin basic protein-reactive T cells in experimental autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;400-409.
48. Sun D., Coleclough C., Whitaker J.N. Nonactivated astrocytes downregulate T cell receptor expression and reduce antigen-specific proliferation and cytokine production of myelin basic protein-reactive T cells. J. Neuroimmunol. 78:1997;69-78.
49. Sun D.M., Hu X.Z., Liu X.H., Whitaker J.N., Walker W.S. Expression of chemokine genes in rat glial cells: the effect of myelin basic protein-reactive encephalitogenic T cells. J. Neurosci. Res. 48:1997;192-200.
50. Swanborg R.H., Swierkosz J.E., Saieg R.G. Studies on the species-variability of experimental allergic encephalomyelitis in guinea pig and rats. J. Immunol. 112:1974;594-600.
51. Taylor-Robinson A.W., Liew F.Y., Severn A., Xu D., McSorley S.J., Garside P., Padron J., Phillips R.S. Regulation of the immune response by nitric oxide differentially produced by T helper type 1 and T helper type 2 cells. Eur. J. Immunol. 24:1994;980-984.
52. Taylor-Robinson A.W. Inhibition of IL-2 production by nitric oxide - a novel self-regulatory mechanism for Th1 cell proliferation. Immunol. Cell Biol. 75:1997;167-175.
53. Tran E.H., Hardin-Pouzet H., Verge G., Owens T. Astrocytes and microglia express inducible nitric oxide synthase in mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 74:1997;121-129.
54. Wahl S.M., Allen J.B., Hines K.L., Imamichi T.X., Wahl A.M., Furcht L.T., McCarthy J.B. Synthetic fibronectin peptides suppress arthritis in rats by interrupting leukocyte adhesion and recruitment. J. Clin. Invest. 94:1994;655-662.
55. Wei X., Charles I.G., Smith A., Ure J., Feng G., Huang F., Xu D., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411.
56. Wekerle H., Sun D. Immune reactivity in the nervous system: modulation of T lymphocyte activation by glial cells. J. Exp. Biol. 132:1987;43-57.
57. Yamamura T., Sun D., Aloisi F., Klinkert W.E.F., Wekerle H. Interaction between oligodendroglia and immune cells: mitogenic effect of an oligodendrocyte precursor cell line on syngeneic T lymphocytes. J. Neurosci. Res. 32:1992;178-189.
58. Yun H.Y., Dawson V.L., Dawson T.M. Neurobiology of nitric oxide. Crit. Rev. Neurobiol. 10:1996;291-316.
59. Zhao W.G., Tilton R.G., Corbett J.A., McDaniel M.L., Misko T.P., Williamson J.R., Cross A.H., Hickey W.F. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J. Neuroimmunol. 64:1996;123-133.
60. Zielasek J., Jung S., Gold R., Liew F.Y., Toyka K.V., Hartung H.P. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:1995;81-88.